Select Publications
Journal articles
2024, 'Surgery for Locally Invasive Thyroid Cancer: Balancing Morbidity with Long Term Outcomes', Annals of Surgical Oncology, http://dx.doi.org/10.1245/s10434-024-16541-w
,2024, 'Reducing noise in radioactive iodine activity selection: the utility of an online clinical calculator', Endocrine Connections, 13, http://dx.doi.org/10.1530/EC-24-0299
,2024, 'Geographic disparities in thyroid cancer staging at presentation: Insights from an Australian context', World Journal of Surgery, 48, pp. 1440 - 1447, http://dx.doi.org/10.1002/wjs.12211
,2024, 'Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma', Histopathology, 84, pp. 947 - 959, http://dx.doi.org/10.1111/his.15141
,2024, 'The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview study', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2022-069236
,2024, 'Codesign of health technology interventions to support best-practice perioperative care and surgical waitlist management.', BMJ Health Care Inform, 31, http://dx.doi.org/10.1136/bmjhci-2023-100928
,2024, 'The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer', Endocrine Practice, 30, pp. 218 - 224, http://dx.doi.org/10.1016/j.eprac.2023.12.008
,2024, 'Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study', Thyroid, 34, pp. 167 - 176, http://dx.doi.org/10.1089/thy.2023.0279
,2024, 'Risk of malignancy in radiologically and cytologically discordant thyroid nodules, based on Thyroid Imaging, Reporting and Data System (TI-RADS) and Bethesda classifications', BJS Open, 8, http://dx.doi.org/10.1093/bjsopen/zrad117
,2024, 'Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocol', Asia-Pacific Journal of Clinical Oncology, http://dx.doi.org/10.1111/ajco.14106
,2024, 'Australian males and females have similar rates of presentation for symptomatic and advanced thyroid cancer: Retrospective analysis of the Australian New Zealand Thyroid Cancer Registry', World Journal of Surgery, http://dx.doi.org/10.1002/wjs.12373
,2024, 'Endocrine surgery fellowship is necessary for competent endocrine surgical practice: perspectives from Australia and New Zealand', ANZ Journal of Surgery, http://dx.doi.org/10.1111/ans.19276
,2024, 'Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program', Surgery (United States), http://dx.doi.org/10.1016/j.surg.2024.05.058
,2024, 'Response to Letter to the Editor From Devgan and Mayilvaganan: “Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma”', Journal of Clinical Endocrinology and Metabolism, 109, pp. E437, http://dx.doi.org/10.1210/clinem/dgad380
,2023, 'A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma—How Much? How Tall? And When Is It Relevant?', Endocrine Pathology, 34, pp. 461 - 470, http://dx.doi.org/10.1007/s12022-023-09788-8
,2023, 'A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma', Modern Pathology, 36, http://dx.doi.org/10.1016/j.modpat.2023.100329
,2023, 'Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative Surgery', Oncologist, 28, pp. 1064 - 1071, http://dx.doi.org/10.1093/oncolo/oyad232
,2023, 'Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma', Journal of Clinical Endocrinology and Metabolism, 108, pp. 2626 - 2634, http://dx.doi.org/10.1210/clinem/dgad173
,2023, 'Minimally invasive adrenalectomy: a cohort study of surgical approach and outcomes', ANZ Journal of Surgery, 93, pp. 2222 - 2228, http://dx.doi.org/10.1111/ans.18443
,2023, 'Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis', Endocrine-Related Cancer, 30, http://dx.doi.org/10.1530/ERC-22-0348
,2023, 'Putting Patients, Not Clinicians, at the Center of Care to Improve Management of Low-risk Thyroid Cancer', JAMA Otolaryngology - Head and Neck Surgery, 149, pp. 459 - 461, http://dx.doi.org/10.1001/jamaoto.2023.0102
,2023, 'Genotype–Phenotype Correlations and Clinical Outcomes in 155 Cases of Pheochromocytoma and Paraganglioma', World Journal of Surgery, 47, pp. 690 - 698, http://dx.doi.org/10.1007/s00268-022-06862-w
,2023, 'The Presence of Typical “BRAFV600E-Like” Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation', Endocrine Pathology, 34, pp. 112 - 118, http://dx.doi.org/10.1007/s12022-022-09747-9
,2023, 'The Prognostic Impact of Extent of Vascular Invasion in Follicular Thyroid Carcinoma', World Journal of Surgery, 47, pp. 412 - 420, http://dx.doi.org/10.1007/s00268-022-06696-6
,2023, 'Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer', Frontiers in Endocrinology, 14, http://dx.doi.org/10.3389/fendo.2023.1160249
,2023, 'Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update.', Endocr Oncol, 3, pp. e220095, http://dx.doi.org/10.1530/EO-22-0095
,2023, 'Clinicopathological and genetic characteristics of diffuse sclerosing papillary thyroid carcinoma', Pathology, 55, pp. S53 - S53, http://dx.doi.org/10.1016/j.pathol.2022.12.169
,2023, 'Massive Biochemically Silent Pheochromocytoma Masquerading as Nonfunctioning Adrenocortical Cancer.', JCEM Case Rep, 1, pp. luad061, http://dx.doi.org/10.1210/jcemcr/luad061
,2022, 'Unexpected deaths after endocrine surgery: learning from rare events using a national audit of surgical mortality', British Journal of Surgery, 109, pp. 1164 - 1171, http://dx.doi.org/10.1093/bjs/znac276
,2022, 'A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer Outcomes', Thyroid, 32, pp. 1201 - 1210, http://dx.doi.org/10.1089/thy.2021.0563
,2022, 'Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy', Thyroid, 32, pp. 1086 - 1093, http://dx.doi.org/10.1089/thy.2022.0109
,2022, 'Factors That Inform Individual Decision Making between Active Surveillance, Hemithyroidectomy and Total Thyroidectomy for Low-Risk Thyroid Cancer: A Scoping Review', Thyroid, 32, pp. 807 - 818, http://dx.doi.org/10.1089/thy.2021.0646
,2022, 'Thyroidectomy in Australia 2022: lessons from 21,000 consecutive cases', ANZ Journal of Surgery, 92, pp. 1626 - 1630, http://dx.doi.org/10.1111/ans.17783
,2022, 'Applying the ‘three buckets’ theory of situational awareness to surgical training: an updated framework', ANZ Journal of Surgery, 92, pp. 1498 - 1501, http://dx.doi.org/10.1111/ans.17741
,2022, 'ASO Author Reflections: Medullary Thyroid Cancer—Establishing Treatment Paradigms in a Rapidly Evolving Therapeutic Landscape', Annals of Surgical Oncology, 29, pp. 72 - 73, http://dx.doi.org/10.1245/s10434-021-10989-w
,2022, 'ASO Visual Abstract: Outcomes of Advanced MTC in the Era of Targeted Therapy', Annals of surgical oncology, 29, pp. 74, http://dx.doi.org/10.1245/s10434-021-11032-8
,2022, 'International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma', Journal of Clinical Oncology, 40, pp. 96 - 103, http://dx.doi.org/10.1200/JCO.21.01329
,2022, 'Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy', Annals of Surgical Oncology, 29, pp. 64 - 71, http://dx.doi.org/10.1245/s10434-021-10980-5
,2022, 'Tumour volume is a predictor of lymphovascular invasion in differentiated small thyroid cancer.', Endocr Oncol, 2, pp. 42 - 49, http://dx.doi.org/10.1530/EO-22-0066
,2021, 'Correction to: Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment (Annals of Surgical Oncology, (2021), 28, 12, (7520-7530), 10.1245/s10434-021-10146-3)', Annals of Surgical Oncology, 28, pp. 891, http://dx.doi.org/10.1245/s10434-021-10440-0
,2021, 'Thyroid cancer clinicians' views and experiences of delayed treatment during the COVID-19 pandemic: An international cross-sectional survey', ANZ Journal of Surgery, 91, pp. 2562 - 2564, http://dx.doi.org/10.1111/ans.17128
,2021, 'What is the Accuracy of the ACS-NSQIP Surgical Risk Calculator in Emergency Abdominal Surgery? A Meta-Analysis', Journal of Surgical Research, 268, pp. 300 - 307, http://dx.doi.org/10.1016/j.jss.2021.07.009
,2021, 'Focused parathyroidectomy without intraoperative parathyroid hormone measurement in primary hyperparathyroidism: Still a valid approach?', Surgery (United States), 170, pp. 1383 - 1388, http://dx.doi.org/10.1016/j.surg.2021.05.030
,2021, 'Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment', Annals of Surgical Oncology, 28, pp. 7520 - 7530, http://dx.doi.org/10.1245/s10434-021-10146-3
,2021, 'Pros and cons of hemi-thyroidectomy for low-risk differentiated thyroid cancer', ANZ Journal of Surgery, 91, pp. 1704 - 1710, http://dx.doi.org/10.1111/ans.16553
,2021, 'Erratum: Correction to: The PanSurg-PREDICT Study: Endocrine Surgery During the COVID-19 Pandemic (World journal of surgery (2021) 45 8 (2315-2324))', World journal of surgery, 45, pp. 2325, http://dx.doi.org/10.1007/s00268-021-06171-8
,2021, 'The PanSurg-PREDICT Study: Endocrine Surgery During the COVID-19 Pandemic', World Journal of Surgery, 45, pp. 2315 - 2324, http://dx.doi.org/10.1007/s00268-021-06099-z
,2021, 'Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre Experience', European Thyroid Journal, 10, pp. 408 - 415, http://dx.doi.org/10.1159/000516358
,2021, 'Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer', American Journal of Surgery, 221, pp. 886 - 892, http://dx.doi.org/10.1016/j.amjsurg.2020.08.012
,2021, 'An unusual case of a penetrating neck injury (PNI) illustrating the use of a “no zone” approach for the management of this injury and a review of the literature', Trauma Case Reports, 32, http://dx.doi.org/10.1016/j.tcr.2021.100402
,